Brand Peptide Medix
Category Weight Management Blends
Form Co-lyophilized powder, sealed glass vial with flip-off seal
Available sizes 10 mg total (7.5 mg tirzepatide / 2.5 mg cagrilintide); 20 mg total (15 mg / 5 mg)
Blend ratio 3:1 tirzepatide to cagrilintide by mass
Purity ≥99% by HPLC for each peptide; lot-matched COA available
Component 1 Tirzepatide — CAS 2023788-19-2, C225H348N48O68, 4813.45 g/mol
Component 2 Cagrilintide — CAS 1415456-99-3, 4409.07 g/mol
Tirzepatide class Acylated dual GIP/GLP-1 receptor agonist (twincretin), 39 residues
Cagrilintide class Long-acting acylated amylin (IAPP) analog
Key modifications Aib substitutions and a C20 diacid on tirzepatide; anti-fibrillation substitutions, disulfide and lipid chain on cagrilintide
Receptors studied GIP receptor, GLP-1 receptor, calcitonin receptor and AMY1–AMY3 complexes
Research areas Incretin-amylin combination pharmacology, satiation signalling, gastric emptying, adipose and glucose-handling models
Solubility Bacteriostatic water; dilute alkaline or phosphate buffers where assay pH matters
Storage (lyophilized) −20 °C, sealed and protected from light and moisture
Storage (reconstituted) 2–8 °C, protected from light; use within the study window
SKU TIRZEPATIDE-CAGRILINTIDE-10-MG-7-5-2-5